British Journal of Renal Medicine - 2001


Comment: Turning 40
John Bradley
pp 4-4
The National Kidney Research Fund (NKRF) turned 40 this year, alongside a number of celebrities who have lent their support to the charity. George Clooney, Meg Ryan, Martin Kemp, Carol Vorderman, Eddie Murphy and Martin Clunes have been among the stars who shared their 40th birthday celebrations. The NKRF has a mission to improve the health and wellbeing of people living with kidney disease. At a birthday party on 3 July the NKRF was able to honour its founders, reflect on its achievements and look to the future.
Dialytic therapies for acute renal failure in the ICU
Geoffrey Bihl
pp 6-9
Despite recent advances, the management of acute renal failure (ARF) in the intensive care unit (ICU) remains something of a challenge. In the previous issue of the British Journal of Renal Medicine, the non-dialytic options were discussed. This article will focus on dialytic therapies and the controversies that exist in the area of dialysis/renal replacement therapy (RRT).
The Kidney Alliance’s shadow NSF for renal services
Dr Roger Greenwood
pp 10-12
In the House of Commons in January this year, the Kidney Alliance (KA) launched End stage renal failure – a framework for planning and service delivery as part of its strategy to achieve equity and excellence in renal services. What is the KA, what was special about this document, and why the House of Commons? The KA was established three years ago following discussions of the then Chair of the National Kidney Federation (NKF), Austin Donohoe, with leaders of different professional groups.
What I tell my patients about diabetes and their kidneys
Dr AC Felix Burden
pp 13-16
This article will be of interest to people whose diabetes may be affecting their kidneys. It does not intend to answer all of your questions, but rather to suggest questions that you can ask your doctor, dietitian or nurse. If you have diabetes it does not necessarily mean that any kidney problems you develop will have been caused by the diabetes. Someone with diabetes is just as likely as anyone else to have some sort of kidney problems. You should ask your doctor to explain what the likely cause of your kidney problem is.
The challenges of geriatric nephrology
Nada Dimkovic, Sarbjit V Jassal and Dimitrios G Oreopoulos
pp 17-20
The aging kidney has many characteristics which make it different from the younger organ. Nephrologists caring for elderly patients are faced with specific challenges that relate to renal histology and function, diagnostic difficulties and therapeutic options. The increasing numbers of elderly patients with renal disease mean that nephrologists familiar with these peculiarities will be able to provide better care to their older patients.
Nutritional assessment and supplementation in patients with end-stage renal failure
Anne Griffiths and Barbara Engel
pp 21-24
Malnutrition in the dialysis population increases mortality and morbidity. Studies evaluating the nutritional status of end-stage renal failure patients have reported a varying prevalence of malnutrition, from 20–50%, depending on the criteria used. Many patients enter the renal replacement therapy (RRT) programme with incipient malnutrition, which is multifactorial. For example, uraemic state, increased catabolism, prolonged poor nutritional intake, and unmonitored therapeutic or self-imposed diets may all contribute.
Help for patients with cystinosis and their carers
Jonathan Terry
pp 25-25
In 1997 the British Journal of Renal Medicine published an article by Dr William van’t Hoff entitled Nephropathic cystinosis – from infancy to adulthood. It explained how the accumulation of cystine that occurs in cystinosis interferes with normal cellular function. Cystinosis belongs to the group of disorders classified as inborn errors of metabolism. There are many types of metabolic disorder. They all have different features, depending upon which process it is that they affect.

The British Journal of Renal Medicine was previously supported by Baxter Healthcare from 2011 to 2013, by Sandoz in 2011, by Shire Pharmaceuticals from 2006 to 2011, by Ortho Biotech and Shire Pharmaceuticals in 2005, by Ortho Biotech from 2000 to 2005 and by Janssen Cilag from 1996 to 2000.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly, the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title British Journal of Renal Medicine is the property of Hayward Group Ltd and, together with the content, is bound by copyright. Copyright © 2017 Hayward Group Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk

ISSN 1365-5604 (Print)  ISSN 2045-7839 (Online)